Catalog Number D134805 |
Device Problems
Off-Label Use (1494); Patient Device Interaction Problem (4001)
|
Patient Problem
Cardiac Tamponade (2226)
|
Event Date 10/04/2023 |
Event Type
Injury
|
Event Description
|
It was reported that a patient underwent a ventricular tachycardia (vt) ablation procedure using a thermocool® smart touch® sf bi-directional navigation catheter.The patient experienced cardiac tamponade that required pericardiocentesis and prolonged hospitalization.This was a case of epicardial ablation in a procedure for vt.No defects or errors have been observed with the product used intraoperatively.Postoperatively, cardiac tamponade was observed, and pericardial drainage was performed and a drain tube was placed.The patient was returned to the intensive care unit (icu).The procedure had been completed.Transseptal puncture was not performed.Pericardial effusion or tamponade was not identified during ablation.Steam pop was not confirmed.The physician's opinion on the adverse event was possibly intercostal artery was injured.This is not an adverse event caused by a product defect.No abnormalities observed prior to or during use of the product.
|
|
Manufacturer Narrative
|
E1.Initial reporter address line 1 (cont.): (b)(6).E.1.Initial reporter phone: (b)(6).The device has been reported as discarded, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device 31099933l number, and no internal action related to the complaint was found during the review.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
|
Manufacturer Narrative
|
On 01-nov-2023, additional information was received, and it was reported that the patient improved.Also, after internal review on 02-nov-2023, the h 6.Medical device problem code of ¿off-label use (a2304)¿ was added since the reporter mentioned contraindication with epicardial ablation.Also, in the catheter¿s instruction for use (ifu), it described directions for endocardial ablations (no mention of epicardial ablation).If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|